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Abstract
Background and purpose: In Europe, the EU Directive 2001/18/EC lays out the main provisions of environmental
risk assessment (ERA) of genetically modified (GM) organisms that are interpreted very differently by different
stakeholders. The purpose of this paper is to: (a) describe the current implementation of ERA of GM plants in the
EU and its scientific shortcomings, (b) present an improved ERA concept through the integration of a previously
developed selection procedure for identification of non-target testing organisms into the ERA framework as laid
out in the EU Directive 2001/18/EC and its supplement material (Commission Decision 2002/623/EC), (c) describe
the activities to be carried out in each component of the ERA and (d) propose a hierarchical testing scheme. Lastly,
we illustrate the outcomes for three different crop case examples.
Main features: Implementation of the current ERA concept of GM cro p si nt h eE Ui sb a s e do na ni n t e r p r e t a t i o no ft h e
EU regulations that focuses almost exclusively on the isolated bacteria-produced novel proteins with little consideration of
the whole plant. Therefore, testing procedures for the effect assessment of GM plants on non-target organisms largely
follow the ecotoxicological testing strategy developed for pesticides. This presumes that any potential adverse effect of
the whole GM plant and the plant-produced novel compound can be extrapolated from testing of the isolated bacteria-
produced novel compound or can be detected in agronomic field trials. This has led to persisting scientific criticism.
Results: Based on the EU ERA framework, we present an improved ERA concept that is system oriented with the
GM plant at the centre and integrates a procedure for selection of testing organisms that do occur in the receiving
environment. We also propose a hierarchical testing scheme from laboratory studies to field trials and we illustrate
the outcomes for three different crop case examples.
Conclusions and recommendations: Our proposed concept can alleviate a number of deficits identified in the
current approach to ERA of GM plants. It allows the ERA to be tailored to the GM plant case and the receiving
environment.
Background and purpose
In most countries of the world, genetically modified
(GM) organisms are subject to regulation. In Europe
and all countries that are signatories to the Cartagena
Protocol, environmental risk assessment (ERA) is
required for the regulatory approval of GM organisms
(GMO) (CBD 2000, Annex II; 6; 1, Annex III) [1].
Scientific requirements of ERA of GM plants in the
European Union
ERA as defined in the European Union (EU) legislation
has to evaluate the ‘risks to human health and the
environment, whether direct or indirect, immediate or
delayed, which the deliberate release or the placing on
the market of GMOs may pose’ (EC 2001, Annex II) [2].
In addition, potential cumulative long-term effects have
to be analysed. The EU Directive 2001/18 (EC 2001,
Annex II) [2] further describes the different ‘effect cate-
gories’ to be considered. ‘Direct effects’ are primary
effects on human health and the environment which are
the result of the GMO itself and which do not occur
through a causal chain of events. ‘Indirect effects’ are
effects ‘occurring through a causal chain of events,
through mechanisms such as interactions with other
organisms, transfer of genetic material, or changes in
use or management of the crop’ (EC 2001, Annex II)
[2]. ‘Immediate effects’ refer to effects ‘which are
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Immediate effects may be direct or indirect.’‘ Delayed
effects’ are effects ‘which may not be observed during
the period of the release of the GMO but become
apparent as a direct or indirect effect either at a later
stage or after termination of the release’ [2]. All this
should be done on a case-by-case basis, in a stepwise
fashion and properly consider uncertainty and knowl-
edge gaps [2,3]. Last but not least, EU legislation states
that ‘The precautionary principle has been taken into
account in the drafting of this directive and must be
taken into account when implementing it’ [2,4]. While
these provisions give guidance, a heated debate persists
just on how they should be interpreted, and, more
importantly, implemented [5]. In our view, the current
implementation of ERA falls short of complying with
the EU regulations.
Purpose
The purpose of this paper is to address the following
objectives: (a) to describe the current implementation of
ERA of GM plants in the EU and its scientific short-
comings, (b) to present an improved ERA concept
through the integration of a previously developed
selection procedure for identification of non-target test-
ing organisms into the ERA framework as laid out in
the EU Directive 2001/18/EC [2] and its supplement
material [3,6], (c) to describe the activities to be carried
out in each component of the ERA and (d) propose a
hierarchical testing scheme. Lastly, we illustrate the out-
comes for different crop case examples (Table 1).
Current implementation of ERA of GM plants and its
deficits
The ERA of GM plants currently focuses only on the
novel trait and the novel substance (e.g. Bt-toxins, see
below) expressed therein (Table 1). This interpretation
was precedented by the US regulations [7] and found
support by corporate developers of GM plants and some
governmental regulators of GM organisms in the US
and Europe [8,9]. This current implementation of the
regulations of GM plants is grounded in the concept of
‘substantial equivalence’ of GM plants and its non-trans-
formed counterparts [10-12]. In order to demonstrate
that a GM plant is substantially equivalent to the non-
transformed parent plant, a number of basic compounds
are measured and compared not only between the GM
and non-GM cultivars but also to any published data of
Table 1 Comparison of current and alternative approaches to environmental risk assessment of genetically modified
organisms
Current ERA model Alternative ERA model
Focus Novel trait = novel protein (pesticide model) as
separate singular component
GMO (novel protein is integral component)
Stressor (characteristic causing
adverse effect)
Primary Primary (= GMO)
= novel trait Secondary (any other measure required to realize
benefit and intended effect of GMO)
= novel protein
Test material Bacteria-produced and purified novel protein Bacteria-produced and purified novel protein
Pollen Pollen
GMO
Tested effects
Direct acute effects Yes Yes
Direct chronic effects No, unless significant adverse direct effects at low
tier
Yes, for selected species
Indirect effects No, unless significant adverse direct effects at low
tier
Yes, for selected species
Interaction effects with other
primary and secondary plant
compounds and/or the environment
No, unless significant adverse direct effects at low
tier
Yes, for selected species
Test organisms Standard set of universal testing species,
representative for trophic levels of a generic
ecosystem (i.e., first producer, first consumer, second
consumer, etc.) according to OECD [33] guidelines
for pesticide testing
Procedure for case-specific selection of suitable testing
species, representative for important ecological
functions of the receiving environments
Testing procedures Prescriptive regarding detailed standardised
experimental protocols according to OECD [33]
guidelines for pesticide testing
Prescriptive regarding procedure to develop proper
risk hypotheses and derive relevant testing protocols
for the selected testing species
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publications predating World War II) [13]. Typically,
the measured compounds are amino acids, total protein,
fatty acids, carbohydrates, and occasionally anti-nutri-
ents like glucosinolate in oilseed rape or solanine in
potato. Although OECD consensus documents on com-
positional considerations have been published for var-
ious crops, no mandatory guidelines exist regarding
what to test and how similar the values should be in
order to still comply with being ‘equivalent’.M o s t
importantly, the degree of difference between a non-
transformed parent cultivar or any other cultivar of the
same plant species and the GM event is not defined
[14]. From personal experience of some of the authors
of this article with data submitted in dossiers of GM
plants seeking regulatory approval, these substantial
equivalence data do frequently yield significant differ-
ences even outside of reported ranges for other (at
times ‘historic’) cultivars but are then dismissed as ‘bio-
logically irrelevant’. The substantial equivalence (or
familiarity) concept is therefore highly contested in par-
ticular with regard to its relevance for biosafety evalua-
tions as it serves as the prime screen for unintended
effects [14-16]. According to the developers of GM
plants and some government regulators, the declaration
of substantial equivalence legitimates to omit testing for
anything but initial acute, short-term effects of the iso-
lated bacteria-produced toxin [8,9,17]: ‘If [...] the only
difference found between the GM plant and the non-
GM comparator is the newly expressed protein(s), the
risk assessment can focus on the potential effects of this
protein(s)’ [8,9,12]. Or: ‘If the transgenic plant does not
differ from its near isoline, the stressor that needs to be
assessed is simply the introduced trait (e.g. the
expressed Cry protein) and not the whole plant.’ [12]. It
is assumed that such initial tests using isolated bacteria-
produced surrogate proteins are sufficiently reliable indi-
cators for the required assessment of ‘indirect’, ‘delayed’
and ‘cumulative’ effects of the whole GM organism,
including interaction effects of any existing secondary
compounds (e.g. glycoalkaloids, glucosinolates) with the
expressed novel toxins. If these acute toxicity tests do
not yield data of concern any further testing in the
environment for broader and more long-term effects is
deemed obsolete [8,12]. However, even for chemicals,
this strategy is by no means uncontroversial [18-20]. For
GM organisms, a further dimension of complexity
arises. Not only is the lab-to-field extrapolation of the
tested chemical debatable but, under the current
approach, we additionally extrapolate from an isolated
chemical surrogate (tested in the lab) to a complex liv-
ing biological organism (in the field).
In practice, it also means that for GM plants that do
not express a ‘novel’ pesticidal protein, as herbicide
resistant (HR) crops or GM plants with altered primary
compounds, like starch-altered GM crops, either no
stressors are identified or their relevance is dismissed.
This applies especially to the most widely used GM
plants worldwide, HR crops. The vast majority of them
are resistant to the broad spectrum herbicide glyphosate.
The considered novel trait/protein (i.e. stressor) is a
substitute enzyme from a microorganism (e.g. CP4
EPSPS conferring resistance to glyphosate) that is simi-
lar but not identical to the one naturally occurring in
the conventional plants. It is in such significantly differ-
ent as it enables the GM crop to continue the synthesis
of essential amino acids which in non-GM plants is
blocked by the corresponding broadspectrum herbicide
- as a result, all plants except the HR crop die. However,
for biosafety purposes, it is not considered a ‘novel’
compound and usually no testing for adverse effects of the
whole GM plant is deemed necessary (Table 1). Occasion-
ally, however, some toxicity tests with the new, again, bac-
teria-produced enzyme are performed. Based on this logic,
the adverse effects of the broad-spectrum herbicide (on
non-target flora and fauna and the evolution of resistant
weeds) required to benefit from the technology, are
excluded from the ERA [13,21]. Some ecotoxicological
aspects are considered in the registration of the pesticide
(typically only submitted as request for extension of cur-
rent use) but are not submitted in the context of the ERA
of the GMO. Consequently, it is also not taken into
account that GM HR crops do now contain higher con-
centrations of residues of the applied systemic herbicide,
like glyphosate and its metabolite AMPA, than under the
conventional use of these herbicides [22-24]. Aside of the
health issues associated with any pesticide residue in food
and feed, these higher herbicide residues have also an
associated ecotoxicological dimension with regard to input
pathways, persistence and bioactivity of pesticide residues
in the ecosystem, in addition to the herbicide residues
resulting from the external application. Further ignored
are any unintended changes in the activity pattern of both
the novel and native enzymes produced in the GM plant.
We argue that these are serious shortcomings of the cur-
rent approach to ERA of GM plants and identify the
urgent need for improvement.
Proposal for a scientifically improved ERA concept
complying with EU regulations
We propose a scientifically improved ERA concept that
places the whole GM organism at the centre of the
assessment. This includes potential adverse effects aris-
ing from direct and indirect exposure to the whole GM
plant and from secondary stressors that are required to
realise the benefit and intended effect(s) of the GM
plant, such as the application of broad spectrum herbi-
cides (Table 1) [25].
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beyond and above previously published material: (a) we
integrate the selection procedures for identification of
non-target testing organisms into the ERA framework as
outlined in the EU Directive 2001/18/EC [2] and supple-
mented by the Guidance Notes of the EU Commission
2002/623/EC [3] and (b) describe the activities to car-
ried out in each component of the ERA. This will
address the components I - IV which represent a risk
assessment sensu strictu. Furthermore, we propose a
hierarchical testing scheme. Moreover, we contrast the
activities we propose to be carried out under the first
three components of the ERA framework to those pro-
posed following the currently applied approach to ERA
in Table 1 in order to highlight the improvements.
Lastly, we illustrate the outcomes for three different
crop case examples.
The selection procedure which we integrate into the
EU Directive ERA framework is the outcome of the
‘GMO ERA Project’ produced by an international group
of scientists from the global working group ‘Transgenic
Organisms in IPM and Biocontrol’ run under the aus-
pices of the IOBC (International Organisation for Biolo-
gical Control) [21,26-29] (Figure 1).
Hazard identification - the scope of ERA
In this first component of the ERA framework, EU legis-
lation requires the ‘identification of characteristics which
may cause adverse effects’ (Figure 1). This component is
the most critical part of the ERA, as it is here where the
scope of the ERA is determined.
Defining the ‘case’
For an inclusive approach of ERA to be compliant with
the EU regulations, it is reasonable to begin this process
by defining and describing the ‘case’ to be assessed. This
constitutes the basis for building the process in a sys-
tematic and transparent manner. Based on the provi-
sions put forward by the Directive 2001/18/EC [2] and,
similarly by the Cartagena Protocol on Biosafety [1], a
case is described by the three elements: (1) the crop
plant, (2) the novel trait relating to its intended effect
and phenotypic characteristics of the GM plant and (3)
the receiving environment relating to the intended use
of the GM plant. For each element, information must be
compiled and synthesised.
For the crop plant, any information on its biology,
ecology and current spatio-temporal agronomic use and
limitations of use is compiled. For the novel trait, this
includes comprehensive information on the molecular
characterization of the GM plant, its introduced genetic
material and tissue-specific expression of the novel pro-
teins. Information on the intended effect(s) include(s)
for example all available data on the problem to be
solved with the proposed GM plant, efficacy data of the
GM plant demonstrating the ability to solve that pro-
blem, the severity of the problem, how widespread the
problem is and who is mostly affected by the problem.
I. Hazard identification
2001/18: Identification of characteristics which
may cause adverse effects
Problem formulation (i.e., case definition)
II. Effect determination
2001/18: Evaluation of the potential 
consequences of each adverse
effect, if it occurs
Practical testing
III. Exposure assessment
2001/18: Evaluation of the likelihood
of the occurrence of each identified
potential adverse effect
Estimation or measurement
IV. Risk characterization
2001/18: Estimation of the risk posed by
each identified characteristic of the GMO(s)
Effect / exposure comparison
V. and VI. Risk management
2001/18: Application of management strategies
for risks from the deliberate release or
marketing of GMO(s); 
Determination of the overall risk of the GMO(s)
The following steps are not covered in this report
Figure 1 Components of ERA scheme as laid out in Commission Decision 2002/623/EC supplementing EU Directive 2001/18/EC.
Proposed activities added in italics.
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scientists have developed a stakeholder process and
tested it for the use in ERA of GM organisms [30,31].
This procedure was recently transformed into a practical
guidance handbook [32]. Such a systematic process
allows to identify the main users of the GM plant, and
to estimate the potential adoption rate and spread of the
GMO after release. This in turn allows to delineate the
potential receiving environments and focus the analysis
on those where the adoption is expected to be greatest
with the assumption that potential adverse environmen-
tal effects will likely manifest firstly and foremost where
the GM crop is grown most frequently and most wide-
spread. Finally, the identification of the potential receiv-
ing environments is essential to characterise the existing
biodiversity and ecological processes that might be
affected and from which the candidate testing species
will be selected (see next section).
What species to test?
Under the current ERA model, ecotoxicological testing
follows closely the methodologies developed for environ-
mental chemicals like pesticides [33]. These are pre-
scriptive with regard to the testing organisms and
detailed testing protocols. Testing organisms are chosen
from a list of universal standard species that are repre-
sentative for trophic levels in general rather than present
in a given receiving environment (Table 1) [25].
Our proposed methodology for testing of non-target
o r g a n i s m si sp r e s c r i p t i v ew i t hr e g a r dt ot h eu s eo fa
procedure for selection of testing species and the devel-
opment of proper testing protocols and risk hypotheses
tailored to each case and receiving environment. This
procedure was developed and tested for three case
examples by the ‘GMO ERA Project’,f o rd e t a i l e d
description of the selection procedure and outcomes of
the test run see the series of publications by
[28,27,34,35]. Here, we only provide a brief summary
(Figure 2).
The selection procedure is a step-wise process that
begins with identifying the most important ecological
functions relevant to the sustainable production of the
GM plant (Figure 2). Based on the information obtained
from the characterization of the existing biodiversity in
the identified receiving environments, a list of the most
relevant functional groups for the given cropping system
is compiled and the identified species are classified
according to their known ecological functions (Step 1,
Figure 2). Next, a defined set of ecological criteria is
used to select the most important species of each func-
tional category. Each species is ranked according to its
geographic distribution, habitat specialization, abun-
dance, phenology, linkage and association with the crop
(Step 2, Figure 2). As this step is largely independent of
the genetically engineered novel trait of the crop plant,
the outcome of these two steps can be used for ERA of
other GM, cases using the same plant/crop species. The
goal is to select those species that rank highest in these
ecological criteria and, therefore, have an important
functional role in that cropping system. The rationale is
that if these species are adversely affected by a GM
plant, it could indeed result in an adverse environmental
effect. These two selection steps greatly reduce the
number of potential testing species existing in a given
cropping system and surrounding habitats while
acknowledging the limitations of the available knowl-
edge about species and their function and identifying
important gaps of information. Only those candidate
species that were ranked highest in these two preceding
steps are taken further along in the procedure. The goal
is that neither all nor too little is required for testing
but a reasonable set of species with greatest relevance to
the receiving environment and an important ecological
function in the given cropping system. The outcome of
this first critical component is the scope and context of
the ERA and the testing strategy tailored to the particu-
lar GM plant case in its receiving environment.
Exposure assessment - from pathways to scenarios and
protocols
For the species ranked highest in the previous compo-
nent, an exposure analysis is conducted to determine
whether or not and to what degree the species come
into contact with the primary stressor, i.e. the GM plant
including the transgene product (e.g. a Bt-toxin) or the
altered composition of primary metabolic compounds
(e.g. starch), or any secondary stressor required for rea-
lizing the transgenic function of the GMP, e.g. the
broad spectrum herbicide for HR GM plants (step 3,
Figure 2). Because the respective transgene products are
integral parts of the GM plants and their expression is
coupled to the physiology and metabolism of the plant,
exposure of associated organisms can be multi-fold and
complex. Exposure can be bitrophic via the GM plant
including any metabolites of the transgene products in
residues, fluids (e.g. phloem) or secretions (e.g. nectar,
root exudates). Exposure of higher order consumers can
occur through multitrophic exposure routes when the
transgene products move through the food web. Also,
after movement and expression of the transgenes in
other genetic contexts (e.g. wild relatives), an entirely
different suite of organisms can get into contact with
the novel transgene products. The same holds true after
spread of the transgene products, such as the Bt-toxin
including any metabolites, away from the field of release
of the GM plant e.g. embedded in wind dispersed GM
pollen or in GM plant residue washed into water sys-
tems like ponds, lakes, creeks and rivers, or leaching of
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possible exposure pathways requires a solid characteriza-
tion of the GM plant and the expressed novel traits and
accompanying management systems. Hence, this step
builds on and is only as good as the information col-
lated in the previous component I. Because GM plants
can multiply and spread via pollen and seed flow, this
exercise will differ significantly from an exposure analy-
sis of chemicals.
Spread of transgene products/metabolites
Currently, there exists little if any data on biogeochem-
ical cycling, spread and fate of transgene products in the
above- and below-ground ecosystems of the receiving
environments and their potentially changing bioactivity
and metabolites in the varying environmental media (e.
g. different soils, composts, manures). Few studies pub-
lished to date have confirmed the suspected spread of
Bt-toxins through food chains in the agroecosystem
[36-39]. Epigaeic predators (ground beetles of the genus
Carabidae) collected in fields where Bt-crops had been
grown two years before still contained Bt-toxin at a
detectable level [37]. Bt-toxins from GM plants enter
the ecosystem via many routes; embedded in living and
decaying plant material, pollen or as toxin leaching and
exudated from roots [40] and in faeces from insects and
animals such as cows fed with Bt-maize feed [41,42].
However, the bioactivity of such metabolites remains
unknown to date. Several experiments studied the
impact of Bt-crop plant material on soil organisms with
variable results ranging from some effects to transient
effects to no effects [43,44].
All of these studies focused on terrestrial agroecosys-
tems. Only recently, the first papers were published that
documented the input of transgene products or trans-
gene DNA into aquatic systems, headwater streams and
rivers [45] and connected them to possible adverse
effects on some aquatic organisms [46,47]. Larger - and
if possible coordinated - research and screening efforts
are necessary to fully understand the spatio-temporal
dimension of spread, persistence and bioactivity of the
novel transgene products, like the Bt-toxins, and their
metabolites embedded within or stemming from the
GM plants in the various receiving ecosystems.
The information compiled in this component II will
allow to further reduce the number of testing species
Case 
definition
Crop biology / Novel trait (intended effect) /
receiving environment (intended use)
Functional groups   
Potential species
Relevant species
Test species
(1 ... n)
(many)
(managable number)
Step 1: Which functional groups are exposed?
Step 2: Ranking of species and functions
Step 3: Exposure pathways            
Step 4: For which relevant species reproducible
test results can be expected?
Practical testing
Part 1:
Ecology
Part 2:
Practicability
Methods
selection
Test methods
Step 5: Development of adverse effects scenarios
Step 6: Formulating adverse effects scenarios as
testable hypotheses and recommendation of
relevant experimental protocols
Species
selection
I Hazard 
Identification & 
Problem
Formulation
II Exposure 
Assessment
III Effect 
Determination
Figure 2 Scheme for selection of testing species and developing relevant testing protocols.
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GM plants and their transgene products/metabolites
under the assumption that these will be the ones most
likely experiencing adverse effects. Modelling exposure
scenarios could assist in this effort.
Adverse effect scenarios and testable hypotheses
Understanding exposure routes and pathways of intro-
duction of GM organisms and their transgene products
into the environment is critically important to develop
adverse effect scenarios and research hypotheses for the
testing of the selected candidate species. We illustrate
this using the three case examples of GM Bt-, HR- and
starch-altered crops (Table 2). At the centre of the ERA
under the broader model is always the whole plant
including its transgene product(s) and intended effect(s)
(Table 2).
For Bt-plants, as with any other plant compound, the
novel toxic protein, like the Cry toxins of Bt-crops, must
be expected to be ingested by almost all herbivores feed-
ing on these crops and moving through the associated
food chain. During this process, the novel protein can
take on new properties as it is biochemically altered/bro-
ken down during the passage through the various gut
milieus and may exert effects at higher trophic levels in
an entirely unexpected way. Such effects cannot be
predicted for example from the known mode of action
stemming almost exclusively from a very restricted group
of organisms, the target pest herbivores [48].
For GM HR crops, the stressor is the GM plant that
triggers a secondary stressor, the application of broad
spectrum herbicides like glyphosate or glufosinate. The
use of these herbicides that were registered a long time
ago can differ significantly in conjunction with HR
crops from its conventional use and may give rise to
adverse effect scenarios beyond and above those under
its conventional use (see Farm Scale Evaluations) [49].
In the starch-altered GM crops, primary compound
composition will be substantially if not radically altered
compared to their conventional counterparts. For exam-
ple, amylose synthesis is down-regulated close to nil
while amylopectin production is up-regulated and con-
stitutes the almost sole starch component in such a GM
crop. Altered primary metabolism (e.g. starch) must also
be expected to affect the food chain associated with
these GM plants [50]. In the ecological and entomologi-
cal scientific literature evidence for the mutual influence
of plant compounds and herbivores on the evolution of
both, the plants and their (pest) herbivores has been
reported [50,51].
Experiments are necessary to deliver solid data that
confirm or refute predicted routes of exposure,
Table 2 Illustrative classifications for types of properties, stressors, adverse effect scenarios and testable hypotheses
GM crop Bt crop HR crop Starch-altered crop
Property
causing
adverse
effects
Property: insect resistance Property: herbicide resistance Property: altered starch composition
Mechanism: expression of toxin Mechanism: Expression of altered EPSPS Mechanism: down- and up-regulation of
existing compounds
Stressor/
mechanism
Primary: Bt-crop and Bt toxin as integral
component
Primary: HR-crop and altered EPSPS protein
as integral component
Primary:
High amylopectin content
No amylose content
Secondary: none Secondary: Herbicide Secondary: none
Adverse
effect
scenario
Increased mortality of a chrysopid predator
feeding on an unaffected plant hopper in Bt
maize leads to reduced biocontrol and
higher plant hopper infestation
Reduction of the local population of a
butterfly species whose larvae feed
monophagously on a certain nontarget
weed plant occurring mainly in oilseed
rape fields.
Increased suitability of amylopectin GM
potato for a virus-transmitting aphid. More
aphids will now transmit more viruses and
create problems for neighbouring crop
plants.
Testable
hypotheses
Higher generational mortality among
chrysopids raised on Bt maize-fed plant
hoppers
Lower densities of caterpillars of the
particular butterfly species in fields treated
with the corresponding herbicide of the HR
oilseed rape than in non-GM oilseed rape
fields
Higher reproduction rate and population
densities of aphids on amylopectin GM
potato than on non-GM isogenic potato
Higher survival of plant hoppers on Bt
maize than on isogenic maize in the
presence of a similar number of same-aged
chrysopid predators
The three case examples Bt-, HR- and starch-altered crops under a broader, alternative ERA model.
At the centre of the ERA is always the whole GM plant.
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exposure level (delivering basic data on transgene pro-
duct metabolism and biological cycling). Developing
adverse effect scenarios builds on the confirmed expo-
sure routes of this component and the information com-
piled on the ecological function(s) of the candidate
species in the previous component I. Please note, since
only those candidate species have remained for this
component that have an important ecological function,
any adverse effect would be significant. Likewise, it may
well be possible to eliminate a number of adverse effect
scenarios already at this early stage if a critical exposure
pathway can be proven to be non-existent or highly
unlikely. For instance, if it can be determined that Bt-
toxins are not present in phloem and xylem sap of GM
Bt-plants at this stage, a whole range of adverse effect
scenarios arising from exposure of aphids, that feed
exclusively on plant sap, and their associated food chain
(s), including many important natural enemies, can be
eliminated. Consequently, component II is critical for
further reduction of the candidate testing organisms
from Component I to those with the highest anticipated
exposure. The outcome of this component II is a map
of all identified exposure pathways and routes of spread
of the GM crop plant, its transgenes and transgene pro-
ducts or the secondary stressors required for the realiza-
tion of the benefit of the GM crop. To do this formally
and in a transparent fashion, the use of the risk analysis
tools called ‘Event-Tree Analysis’ and ‘Fault-Tree Analy-
sis’ is recommended [52]. Fault- and Event-Tree Ana-
lyses are complementary tools used in risk assessment
that were originally developed by engineers identifying
critical steps in complex engineering processes, e.g. avia-
tion or large scale industrial production facilities. In a
modified form, they have been used for environmental
purposes and different ecological systems [53-55].
While, fault-trees work ‘top-down’ beginning with a fail-
ure event (i.e. ‘top-event’), event-trees work ‘bottom-up’
starting with an ‘initiating event’. Both tools graphically
lay out all of the parallel and sequential combinations of
events that can lead to a particular ‘top event’ or arise
from a particular ‘initiating event’. This structured, logi-
cal approach allows to rigorously evaluate the potential
of these events to occur based on scientific data and
expert knowledge, and identifies what data and informa-
tion is necessary to determine reliably the outcome and
the gaps of knowledge associated with the possible
events (Table 2).
Effect determination - doing the testing and generating
the data
The main activity in component III of the ERA frame-
work is the implementation of the testing plan devel-
oped in the two previous components (Figure 2). It
corresponds in such directly to the provision for ‘evalua-
tion of the potential consequences of each adverse
effect, if it occurs’ of the Directive 2001/18/EC [2]. The
aim is to measure whether the GM plant, it’si n t e n d e d
(or perhaps anticipated unintended) use, or the trans-
gene product can affect structural or functional end-
points. Testing should be carried out in a step-wise
fashion [2,3]. The step-by-step principle means that the
containment of genetically engineered organisms is
reduced and the scale of release is increased gradually,
moving from the laboratory to large-scale field testing in
several steps provided the data obtained at the earlier
steps give no reason for concern. This is because inter-
actions with the environment can induce significant dif-
ferences in evolutionary and ecological parameters for
better or worse but certainly unpredictably.
However, again, controversy exists over whether the
evidence for ‘reason for concern’ should be experimen-
tal (i.e. new original data produced) or could be extra-
polated from theory and experience in related fields of
science [8,9,56-58]. Secondly, whether or not an
absence of a ‘reason for concern’ (i.e. evidence) consti-
tutes evidence for safety to the effect that no more
testing at higher levels is required [12,58] is subject to
debate. Here, we briefly outline the basic concept of
our vision for hierarchical testing of GM plants
depicted in Figure 3.
Especially, if significant uncertainties remain at one
level - which is inevitably the case if only a small set of
tests is carried out with surrogate proteins - it is neces-
sary to proceed to the next level with caution. Given
that GMOs can self-reproduce and spread, overlooked
adverse effects can be difficult or impossible to recall
once released into nature. As GM plants and their bio-
chemical products can take on different properties in
different environments and at different ecological orga-
nisational levels (e.g. when moving up the food chain,
see above), data documenting/confirming the lack of
evidence of adverse effects must be produced at every
testing level (Figure 3). In contrast, if at a lower hier-
archical level, i.e. laboratory or greenhouse, a high, diffi-
cult to manage adverse effect is determined, no further
testing may be necessary if the GM plant will not pass
the minimum safety requirements (Figure 3). However,
failure criteria for environmental safety assessments of
GM organisms have yet to be determined and examined
in practice.
If data obtained at higher hierarchical levels do not
support or confirm findings at lower hierarchical levels,
additional laboratory testing with modified experimental
protocols may be necessary to complete the scientific
understanding of the functioning of the GM plant
before moving to experiments at yet higher hierarchical
levels with less or no confinement. Hence, our
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newly generated scientific data (Figure 3). The primary
function of lower hierarchical level testing is to provide
data that allows to focus and to inform the designing of
experiments to be conducted at higher hierarchical
levels. The testing strategy has to be driven by a coher-
ent research risk hypothesis and strategy from the low-
est to the highest tier of testing - a ‘red thread’
connecting the tiered testing programme is essential.
Risk characterization - synthesizing all information
In this component of the ERA framework (Figure 1), the
risk is characterised by combining and comparing the
obtained data and information of the previous three
components. While the emphasis is placed on quantita-
tive data, all gathered qualitative information is also
integrated here. This concurs with the provision of the
‘estimation of the risk posed by each identified charac-
teristic of the GMO(s)’ put forward in the Directive
2001/18/EC [2]). If at a realistic exposure level, signifi-
cant effects can occur, a risk for the environment is
probable. Several outcomes are possible: A high to mod-
erate risk can occur when a strong adverse effect occurs
at a low or moderate exposure level, or, vice versa,
when high exposure (i.e. extensive in space and time)
induces a low to moderate adverse effect. Limited
exposure and small adverse effects (e.g. low toxicity) can
result in low risks, while the opposite is true when a
strong effect coincides with high exposure.
The outcome of activities in this component is a list of
potential risks with an estimation of their strength (high,
moderate or low) that were experimentally confirmed.
Rejected potential adverse effect hypotheses that could
experimentally be proven as unlikely or minor or non-
existent are excluded. Equally important, the delimita-
tion of the ERA and transparent documentation of
remaining uncertainties is identified here. From this,
guidance for possible risk management strategies and
monitoring plans can be derived.
Conclusions
Despite over 10 years of large scale commercial produc-
tion of GM crops in at least five countries, no consensus
on the applied ERA methodologies, let alone agreed
standardised testing procedures exist. Our proposed
concept allows us to alleviate a number of deficits iden-
tified in the current approach to ERA of GM plants.
Firstly, it integrates a procedure for selection of testing
organisms in the formal risk assessment process that,
for one, do occur in the receiving environment and, sec-
ondly, have an important role for those ecological func-
tions that are critical for a sustainable production of the
Ecotoxicity testing
t d
Ecotoxicity testing of nontarget
i d not passed organisms passed
Field testing
Semi-field testing Test 1 Test N
Laboratory testing Test 1 Test N
Test 1 Test N
Figure 3 Proposed tiering scheme for ecotoxicological testing for environmental risk assessment of GM plants.
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Page 9 of 12particular crop. Further, by devising a selection proce-
dure that is embedded in the components of ERA, it
optimally supports the decision making process. In our
approach, only those species will be subjected to testing
that end up being ranked highest regarding their impor-
tance for fundamental ecological functions in that crop
and the greatest likelihood of significant exposure.
Hence, observed adverse effects would constitute a bio-
logically and ecologically meaningful result of concern
that merits further investigation or surveillance. Further,
since the GM plant is at the centre of the testing pro-
gramme, all possible effects, direct and indirect, cumula-
tive and interaction effects are included, thus, complying
with the provision of the EU regulations [2,3]. Addition-
ally, as science-based risk hypotheses and testing proto-
cols are both derived from the selection procedure of
testing organism, it also meets the call for hypothesis-
driven testing regimes [59] and for ‘a method to select
the most important problems’ [60]. Developing and
ranking adverse effect scenarios and formulating testable
risk hypotheses are key elements of our approach.
Further improvements of this concept should now be
carried out in the course of its application to actual
cases in an EU context.
However, we distinctly disagree with the proposal that
ERA of GMOs could be entirely a desk exercise based
on ‘data collected for other purposes’ and may not
require the ‘acquisition of new data’ as put forward by
developers [59,60]. This leads to the current situation
that new GM maize cultivars combining and stacking
different Bt toxins by conventional crossing of various
GM maize varieties enter the market largely untested. A
case in point is the new Bt-maize event called ‘Smart-
stax’ that was recently registered for environmental
release in the USA and Canada [61,62]. This GM maize
combines six insecticidal Bt-toxins and resistance genes
for two broad-spectrum herbicides and entered the mar-
ket with close to no testing for toxic or environmental
impacts relying entirely on ‘the environmental risk
assessment of the individual events’ - except for one
additional study with an unspecified non-target organ-
ism, the results of which are not even summarised [62].
In our view, this is not science based, lacks the required
precaution and entirely puts the discovery of any poten-
tial adverse interaction, cumulative, indirect and long-
term effect of the combined potpourri of six toxins and
two herbicide residues on human and animal health and
the environment in the marketing phase, i.e. the farmer
and consumer. In contrast and consistent with the cur-
rently still prevailing interpretation of the ERA require-
ments, the developers did deliver data on target effects
but almost none on non-target organisms. Just as no
developer could possibly construct and deliver a reliably
efficacious GM organism (i.e. deliver the benefits) based
on ‘data collected entirely for other purposes’ or without
‘new data’ for and with that particular GM organism, its
environmental biosafety cannot be demonstrated with-
out ‘new data’. The same ecological and biological prin-
ciples that preclude the former do so for the latter.
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